Korean J Anesthesiol Search

CLOSE


Korean Journal of Anesthesiology 2001;41(3):269-274.
DOI: https://doi.org/10.4097/kjae.2001.41.3.269   
Adequate Dosage for Midazolam Premedication in Koreans.
Jin Deok Joo, Dae Woo Kim, Jang Hyeok In
Department of Anesthesiology, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Abstract
BACKGROUND
Midazolam is often used as an anxiolytic premedication before surgery. Although the sedative, anxiolytic, and amnestic properties of midazolam may be desirable before the induction of general anesthesia, respiratory function is impaired frequently by larger doses of midazolam. Therefore, we evaluated the adequate doses of midazolam premedication on anxiolytic and sedation without its serious side effects.
METHODS
Eighty ASA I or II adult patients scheduled for elective minor surgery were randomly allocated to four groups according to premedication doses of midazolam. They were group 1: midazolam 0.05 mg/kg IM for lean body mass (LBM); group 2: midazolam 0.075 mg/kg IM for LBM; group 3: midazolam 0.1 mg/kg IM for LBM.; group 4: midazolam 0.125 mg/kg IM for LBM. Blood pressure, heart rate, bispectral index (BIS), oxygen saturation (SpO2), anxiety visual analogue scale (VAS), and observer's assessment of alertness and sedation (OAA/S) scores were measured before and at 30 minutes after midazolam premedication. The frequency of apnea, defined as a cessation of spontaneous respiration for more than 10 seconds, was recorded. Induction time and dose requirements in propofol-induced general anesthesia were recorded at the loss of opening their eyes on verbal command and eyelid reflex after starting the propofol infusion. Following intubation, blood pressure and heart rate were measured.
RESULTS
The bispectral index and anxiety VAS was significantly decreaced in group 3 and group 4. However, oxygen saturation were significantly lower in group 4 compared with group 3.
CONCLUSIONS
We concluded that group 3 (midazolam 0.1 mg/kg IM for LBM) is the proper premedication dosage for anxiolytic and sedation in Koreans without respiratory side effects.
Key Words: target-controlled infusion; lean body mass (LBM); bispectral index (BIS); midazolam


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
AUTHOR INFORMATION
Editorial Office
101-3503, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-792-5128    Fax: +82-2-792-4089    E-mail: journal@anesthesia.or.kr                

Copyright © 2024 by Korean Society of Anesthesiologists.

Developed in M2PI

Close layer
prev next